Screening Protocol for Adults With ADHD

Massachusetts General Hospital3,000 enrolled

Overview

The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential adult subjects for appropriate ADHD clinical research studies

To address the needs of the large number of adults who contact the Adult ADHD Program at Massachusetts General Hospital annually, we have sought approval for several research studies aimed at evaluating critical components of the needs of this population. Potential participants for those studies present with a widely varied set of complaints not always discernable in a telephone screening interview. This state of affairs often makes it difficult to ask subjects to sign a specific protocol's consent form without obtaining additional clinical information. Because of this, we have potential subjects consent to undergo an in-depth clinical assessment that will allow them to be screened by a clinician for eligibility to a diverse clinical research program available to them.

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

ADHD

Eligibility

Sex: ALLMin age: 18 YearsMax age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Males and females ages 18-55 2. Subjects must have a DSM-IV or DSM-V diagnosis of ADHD, as determined by a clinical evaluation based on DSM-IV or DSM-V criteria Exclusion Criteria: 1. History of head trauma with loss of consciousness, organic brain disorders, seizures, or neurosurgical intervention. 2. Any significant medical condition, in the judgment of the investigator 3. Mental retardation 4. Pregnancy of lactation 5. Subjects with a known recent history (within the past 6 months) of illicit drug or alcohol dependence 6. Sensory difficulties such as deafness or blindness

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States

Outcomes

Primary Outcomes

Screening Protocol

This study is a prescreening for possible entry into other studies

Time frame: Sreening

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.